Table 3 Patient-based analysis of detectable lesions prior (T1) and during ADT (T2)
Pat | Prostatic lesions [n] | Lymph node metastases [n] | Bone metastases [n] | T-stage | miN-stage | miM-stage | Max_Score | Summed score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T1 | T2 | T1 | T2 | T1 | T2 | T1/T2 | T1 | T2 | T1 | T2 | T1 | T2 | T1 | T2 | |
1 | 1 | 1 | 7 | 2 | 3 | 2 | T3 | N1b | N1b | M1b | M1b | 3 | 2 | 23 | 6 |
2 | 2 | 1 | 4 | 1 | 4 | 1 | T1 | N1b | N1a | M1b | M1b | 3 | 3 | 21 | 7 |
3 | 1 | 1 | 7 | 0 | 5 | 2a | T3 | N1b | N0 | M1b | M1b | 2 | 2 | 21 | 4 |
4 | 1 | 1 | 10 | 7 | 1 | 0 | T3 | N1b | N1b | M1b | M1a | 3 | 3 | 27 | 18 |
5 | 1 | 1 | 1 | 1 | 2 | 1 | T2 | N1a | N1a | M1b | M1b | 2 | 2 | 5 | 4 |
6 | 1 | 1 | 2 | 1 | 1 | 1 | T2 | N1b | N1a | M1b | M1b | 2 | 3 | 8 | 6 |
7 | 1 | 1 | 6 | 0 | 0 | 0 | T3 | N1b | N0 | M1a | M0 | 3 | 2 | 15 | 2 |
8 | 1 | 0 | 0 | 0 | 3 | 1 | T3 | N0 | N0 | M1b | M1b | 2 | 0 | 6 | 0 |
9 | 1 | 1 | 1 | 0 | 0 | 0 | T1 | N0 | N0 | M1a | M0 | 2 | 1 | 3 | 1 |
10 | 1 | 1 | 0 | 0 | 1 | 1 | T3 | N0 | N0 | M1b | M1b | 2 | 2 | 4 | 4 |
11 | 1 | 1 | 5 | 3 | 0 | 0 | T3 | N1b | N1b | M0 | M0 | 3 | 2 | 16 | 6 |
12 | 1 | 0 | 1 | 0 | 2 | 0 | T4 | N1a | N0 | M1b | M0 | 3 | 0 | 8 | 0 |
13 | 1 | 1 | 0 | 0 | 1 | 1 | T1 | N0 | N0 | M1b | M1b | 2 | 2 | 4 | 3 |
14 | 1 | 1 | 1 | 1 | 1 | 0 | T3 | N1a | N1a | M1b | M0 | 2 | 1 | 6 | 2 |
15 | 1 | 1 | 1 | 0 | 0 | 0 | T3 | N1a | N0 | M0 | M0 | 3 | 2 | 5 | 2 |
16 | 1 | 1 | 0 | 0 | 1 | 1 | T2 | N0 | N0 | M1b | M1b | 2 | 2 | 4 | 3 |
17 | 1 | 0 | 5 | 0 | 0 | 0 | T1 | N1b | N0 | M1a | M0 | 2 | 0 | 8 | 0 |
18 | 1 | 1 | 3 | 2 | 1 | 0 | T3 | N1b | N1b | M1b | M0 | 3 | 3 | 8 | 5 |
19 | 2 | 0 | 0 | 0 | 1 | 1 | T3 | N0 | N0 | M1b | M1b | 3 | 1 | 6 | 1 |
20 | 1 | 1 | 1 | 1 | 0 | 0 | T3 | N1a | N1a | M0 | M0 | 3 | 2 | 5 | 3 |
21 | 2 | 2 | 1 | 1 | 0 | 0 | T3 | N1a | N1a | M0 | M0 | 3 | 3 | 9 | 7 |
∑ | 24 | 18 | 56 | 20 | 27 | 12 | 53 | 38 | 212 | 84 | |||||